EA201290098A1 - METHOD OF OBTAINING POLYMERIC COMPOSITIONS BASED ON PROANTOCYANIDINE FOR PHARMACEUTICAL FORMS - Google Patents

METHOD OF OBTAINING POLYMERIC COMPOSITIONS BASED ON PROANTOCYANIDINE FOR PHARMACEUTICAL FORMS

Info

Publication number
EA201290098A1
EA201290098A1 EA201290098A EA201290098A EA201290098A1 EA 201290098 A1 EA201290098 A1 EA 201290098A1 EA 201290098 A EA201290098 A EA 201290098A EA 201290098 A EA201290098 A EA 201290098A EA 201290098 A1 EA201290098 A1 EA 201290098A1
Authority
EA
Eurasian Patent Office
Prior art keywords
proantocyanidine
pharmaceutical forms
proanthocyanidin
compositions based
polymeric compositions
Prior art date
Application number
EA201290098A
Other languages
Russian (ru)
Other versions
EA023814B1 (en
Inventor
Джон Чоу
Нитин Прадхан
Суреш Махадев Кадам
Инчжун Чэнь
Джонатан Тсэнг
Мубин Ахмед Кхан
Випин Кумар Пандей
Original Assignee
Гленмарк Фармасьютикалс Лтд.
Напо Фармасьютикалс Инк.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Гленмарк Фармасьютикалс Лтд., Напо Фармасьютикалс Инк. filed Critical Гленмарк Фармасьютикалс Лтд.
Publication of EA201290098A1 publication Critical patent/EA201290098A1/en
Publication of EA023814B1 publication Critical patent/EA023814B1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/38—Clusiaceae, Hypericaceae or Guttiferae (Hypericum or Mangosteen family), e.g. common St. Johnswort
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/47—Euphorbiaceae (Spurge family), e.g. Ricinus (castorbean)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/284—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone
    • A61K9/2846—Poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5026—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
    • A61K9/5078—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12—Antidiarrhoeals

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Botany (AREA)
  • Medical Informatics (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Compounds Of Unknown Constitution (AREA)

Abstract

Предложены способы получения фармацевтических композиций, содержащих проантоцианидиновый полимер, применяемых для лечения и профилактики различных состояний. В частности, изобретение относится к способу получения фармацевтических форм полимерной композиции на основе проантоцианидина, которая была выделена из Croton spp. или Calophyllum spp. В частности, изобретение относится к способу получения полимерных композиций на основе проантоцианидина, обеспечивающих достижение концентраций и степеней чистоты, подходящих для добавления к фармацевтически эффективным формам.Methods for preparing pharmaceutical compositions containing a proanthocyanidin polymer used for the treatment and prevention of various conditions are proposed. In particular, the invention relates to a method for producing pharmaceutical forms of a polymer composition based on proanthocyanidin, which was isolated from Croton spp. or Calophyllum spp. In particular, the invention relates to a method for producing proanthocyanidin-based polymer compositions, which achieve concentrations and purities suitable for addition to pharmaceutically effective forms.

EA201290098A 2009-08-26 2010-08-24 Method for producing proanthocyanidin polymer compositions for pharmaceutical formulations EA023814B1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IN1962MU2009 2009-08-26
PCT/IB2010/002060 WO2011024049A2 (en) 2009-08-26 2010-08-24 Method for producing proanthocyanidin polymer compositions for pharmaceutical formulations

Publications (2)

Publication Number Publication Date
EA201290098A1 true EA201290098A1 (en) 2013-01-30
EA023814B1 EA023814B1 (en) 2016-07-29

Family

ID=43337818

Family Applications (1)

Application Number Title Priority Date Filing Date
EA201290098A EA023814B1 (en) 2009-08-26 2010-08-24 Method for producing proanthocyanidin polymer compositions for pharmaceutical formulations

Country Status (3)

Country Link
EA (1) EA023814B1 (en)
WO (1) WO2011024049A2 (en)
ZA (1) ZA201202160B (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2639291C2 (en) * 2016-03-29 2017-12-20 Федеральное государственное автономное образовательное учреждение высшего образования "Белгородский государственный национальный исследовательский университет" (НИУ "БелГУ") Method and composition of producing dry forms of blue anthocyanins

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2011320155B2 (en) 2010-10-31 2016-02-25 Napo Pharmaceuticals, Inc. Methods and compositions for treating HIV-associated diarrhea
BR112013018688B1 (en) * 2011-01-27 2021-08-24 Napo Pharmaceuticals, Inc METHOD OF PRODUCTION OF A POLYMER COMPOSITION OF PROANTHOCYANIDINE
CN102210538A (en) * 2011-05-04 2011-10-12 惠州市欧野科技有限公司 Eaglewood powder and latex mixed pillow and manufacturing method thereof
MY197454A (en) * 2011-12-22 2023-06-19 Napo Pharmaceuticals Inc Non-enteric pharmaceutical composition comprising crofelemer
AU2013391738B2 (en) * 2013-06-07 2019-03-14 Lea Shrivastava Composition for topical application comprising glycerol and tannins
US20170095442A1 (en) * 2014-05-29 2017-04-06 Jaguar Animal Health, Inc. Methods of Treating Salmonella-Induced Diarrhea in Non-Human Animals
US20170119834A1 (en) * 2014-05-29 2017-05-04 Jaguar Animal Health, Inc. Methods of Treating Diarrhea in Adult Non-Human Animals
CN105294636B (en) * 2015-11-16 2018-11-27 大兴安岭林格贝寒带生物科技股份有限公司 A method of preparing glucosidase procyanidins
AU2020272641A1 (en) 2019-04-08 2021-11-04 R.P. Scherer Technologies, Llc Analytical method for determining the total amount of a coating polymer in a dosage form
US20220110992A1 (en) * 2020-09-22 2022-04-14 Alphyn Biologics, Llc Topical croton lechleri compositions and their use in the treatment of a bacterial colonization or primary or secondary bacterial infection of an underlying skin disorder
WO2022066812A1 (en) * 2020-09-22 2022-03-31 Alphyn Biologics, Llc Croton lechleri compositions and their use in the treatment of cystic fibrosis
JP2024508454A (en) 2021-02-25 2024-02-27 アルフィン バイオロジックス、エルエルシー Composition for topical skin bacterial skin disease treatment

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5211944A (en) * 1990-10-12 1993-05-18 Shaman Pharmaceuticals, Inc. Proanthocyanidin polymers having antiviral activity and methods of obtaining same
DK0935417T3 (en) * 1996-10-16 2009-08-10 Napo Pharmaceuticals Inc Enteroformulations of proanthocyanidin polymer compositions for diarrhea
WO2000047062A2 (en) * 1999-02-01 2000-08-17 Shaman Pharmaceuticals, Inc. Enteric formulations of proanthocyanidin polymer dietary supplements and methods for preparing same
EP2061327B1 (en) * 2006-05-01 2016-10-05 Napo Pharmaceuticals, Inc. Compositions for treating or preventing inflammatory bowel disease

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2639291C2 (en) * 2016-03-29 2017-12-20 Федеральное государственное автономное образовательное учреждение высшего образования "Белгородский государственный национальный исследовательский университет" (НИУ "БелГУ") Method and composition of producing dry forms of blue anthocyanins

Also Published As

Publication number Publication date
EA023814B1 (en) 2016-07-29
WO2011024049A2 (en) 2011-03-03
WO2011024049A3 (en) 2011-05-19
ZA201202160B (en) 2013-08-28
WO2011024049A9 (en) 2013-04-25

Similar Documents

Publication Publication Date Title
EA201290098A1 (en) METHOD OF OBTAINING POLYMERIC COMPOSITIONS BASED ON PROANTOCYANIDINE FOR PHARMACEUTICAL FORMS
EA201190217A1 (en) SUBSTITUTED 2-ACETAMIDO-5-ARIL-1,2,4-TRIAZOLONES AND THEIR APPLICATION
NZ603332A (en) Sweet flavor modifier
TW200730518A (en) Crystalline forms of docetaxel and processes for their preparation
MA32257B1 (en) Hydroxymethyl pyrrolidines as agonists of beta-3 adrenergic receptors.
WO2010111406A3 (en) Purine derivatives useful as anti - cancer agents
EA201200519A1 (en) STABILIZED LIQUID AND LIOPHYLIZED ADAMTS13 COMPOSITIONS
MY179876A (en) Sweet flavor modifier
MX2009008531A (en) Nitrogen-containing heterocyclyl ketones and methods of use.
EA201170753A1 (en) NALMEPHENA HYDROCHLORIDE DIHYDRATE
MA33803B1 (en) BENZODIAZEPINE BROMODOMAINE INHIBITOR
IN2012DN00971A (en)
UA95644C2 (en) Pyridizinone derivative, pharmaceutical composition and treatment method
IN2012DN01233A (en)
WO2009117676A3 (en) Novel piperidine derivatives as inhibitors of stearoyl-coa desaturase
MX2015007556A (en) Mannose derivatives for treating bacterial infections.
MX2009005460A (en) (s)-n-stereoisomers of 7,8-saturated-4,5-epoxy-morphinanium analogs.
WO2012015986A3 (en) Substituted dioxopiperidinyl phthalimide derivatives
EP2320740A4 (en) Pharmaceutical compositions and methods for producing low impurity concentrations of the same
GEP20115342B (en) New diosmetin derivatives, process for their preparation and pharmaceutical compositions containing them
MX350746B (en) Novel cyclosporin derivatives for the treatment and prevention of a viral infection.
EA201070009A1 (en) DERIVATIVES OF 7-ALKINYL-1,8-NAFTYRIDONES, THEIR RECEIVING AND THEIR APPLICATION IN THERAPY
WO2010032011A8 (en) Anti-fungal therapy
WO2011075822A8 (en) Immunogenic compositions and related methods
EA201200428A1 (en) COMPOSITION AND METHOD FOR TREATING OBESITY

Legal Events

Date Code Title Description
MM4A Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s)

Designated state(s): AM AZ BY KZ KG MD TJ TM

MM4A Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s)

Designated state(s): RU

NF4A Restoration of lapsed right to a eurasian patent

Designated state(s): RU